Valetudo Therapeutics LLC - 30 Apr 2025 SCHEDULE 13D Report for Liminatus Pharma, Inc. Common Stock (LIMN)

Filing Manager: Valetudo Therapeutics LLC
Reporting Manager: Valetudo Therapeutics LLC
Security: Liminatus Pharma, Inc. Common Stock
Symbol: LIMN
Shares outstanding: 26,031,249 shares
Disclosed Ownership: 6,169,406 shares
Ownership: 24%
Form type: SCHEDULE 13D
Filing time: 07 May 2025, 17:11:07 UTC
Date of event: 30 Apr 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Valetudo Therapeutics LLC	24%	6,169,406	6,169,406	0	/s/ Chris Kim	Chris Kim, Chief Executive Officer	0002067359
Chris Kim	24%	6,169,406	6,169,406	0	/s/ Chris Kim	Chris Kim	0001972385